Press Releases

Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019

Feb 14, 2019 7:00am EST

Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville

Feb 11, 2019 7:00am EST

Recro Pharma Amends Athyrium Credit Facility

Jan 02, 2019 7:00am EST

Recro Pharma Amends IV Meloxicam License Agreement with Alkermes

Dec 21, 2018 7:00am EST

Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology

Dec 10, 2018 7:00am EST

Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia

Nov 14, 2018 7:00am EST

Recro Pharma to Participate in Upcoming Investor Conferences

Nov 08, 2018 7:00am EST

Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018

Nov 07, 2018 7:00am EST

Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

Oct 31, 2018 7:00am EDT

Recro Pharma Announces PDUFA Date for IV Meloxicam

Oct 08, 2018 7:00am EDT

1
2
3
4
5
6
7
8
9
10
...15